Deerfield Management Company, L.P. (Series C) Pulmonx Corp Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.84 Billion
- Q1 2024
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Pulmonx Corp stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 20,289 shares of LUNG stock, worth $128,632. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,289Holding current value
$128,632% of portfolio
0.0%Shares
12 transactions
Others Institutions Holding LUNG
# of Institutions
124Shares Held
30.8MCall Options Held
1.2KPut Options Held
1.2K-
Primecap Management CO Pasadena, CA5.74MShares$36.4 Million0.04% of portfolio
-
Black Rock Inc. New York, NY3.04MShares$19.3 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.72MShares$17.2 Million0.06% of portfolio
-
Morgan Stanley New York, NY2.65MShares$16.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.08MShares$13.2 Million0.0% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $236M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...